Many of the TFs in this pathway (for example FOSB , JUNB and NR4A2 ) showed an increasing trend at the last stage of in vivo T cell development, whereas this increase is missing in the in vitro T cells (Fig. 6d ).
1
—
—
Many of the TFs in this pathway (for example FOSB , JUNB and NR4A2 ) showed an increasing trend at the last stage of in vivo T cell development, whereas this increase is missing in the in vitro T cells (Fig. 6d ).